Is tattooing associated with an increased risk of cancer? A systematic review and meta-analysis
Open Access
- 6 June 2026
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (11) , 5570-5580
Abstract
Background: Tattoo inks may contain carcinogenic compounds, and pigment migration to lymphatic tissues raises concerns regarding potential cancer risk. Epidemiological evidence remains inconclusive. Objectives: To assess the association between tattoo exposure and the incidence of skin cancer and hematological malignancies. Methods: PubMed, Embase, and the Cochrane Library were searched from inception to January 2026 for cohort and case–control studies comparing cancer incidence in tattooed versus non-tattooed adults. Random-effects meta-analyses using restricted maximum-likelihood estimators were performed to pool odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity was quantified using I 2 statistics. Risk of bias was assessed using ROBINS-E, and certainty of evidence was evaluated with GRADE. Leave-one-out sensitivity analyses were conducted. Results: Seven observational studies including 140,841 participants were analyzed. Tattoo exposure was not associated with overall skin cancer (OR 0.92; 95%CI 0.83–1.04; I 2 = 0%; p = 0.179). Stratified analyses by number of tattoo sessions showed no significant associations: one session (OR 1.08; 95%CI 0.55–2.12; I 2 = 92.4%), two-to-three sessions (OR 0.90; 95%CI 0.62–1.32; I 2 = 63.2%), and ≥ 4 sessions (OR 0.70; 95%CI 0.29–1.70; I 2 = 88.5%). For hematological malignancies, pooled analysis showed no significant association (OR 1.02; 95%CI 0.78–1.32; I 2 = 64.9%; p = 0.910). Subtype analyses were non-significant: non-Hodgkin lymphoma (OR 1.00; 95%CI 0.73–1.36; I 2 = 3.7%), Hodgkin lymphoma (OR 1.19; 95%CI 0.59–2.40; I 2 = 91.7%), diffuse large B-cell lymphoma (OR 0.90; 95%CI 0.57–1.44; I 2 = 61.7%), T-cell lymphoma (OR 1.07; 95%CI 0.61–1.88; I 2 = 0%), and follicular lymphoma (OR 0.99; 95%CI 0.72–1.36; I 2 = 1.9%). Sensitivity analysis excluding one influential study rendered the association for overall hematological malignancies statistically significant (OR 1.20; 95%CI 1.05–1.39; I 2 = 0%). Certainty of evidence ranged from low to moderate. Conclusions: Tattoo exposure was not associated with increased skin cancer risk and showed no significant association with hematological malignancies in primary analyses. A significant association emerged only after sensitivity analysis, warranting cautious interpretation and further prospective investigation.Keywords
Funding Information
- Universidade Federal de Santa Maria
This publication has 47 references indexed in Scilit:
- Investigating the potential association between tattoos and lymphoma: an exploratory systematic review and meta-analysiseClinicalMedicine, 2025
- Tattoos and cutaneous squamous cell carcinoma: a population-based case-control studyEuropean Journal of Epidemiology, 2025
- Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in UtahCancer Medicine, 2024
- Tattoos as a risk factor for malignant lymphoma: a population-based case–control studyeClinicalMedicine, 2024
- A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)Environment International, 2024
- MOOSE Reporting Guidelines for Meta-analyses of Observational StudiesJAMA Surgery, 2021
- Mélanomes sur tatouage : deux observations et revue systématique de la littératureAnnales de Dermatologie et de Vénéréologie, 2020
- Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of InterventionsCochrane Database of Systematic Reviews, 2019
- Trendy Tattoos—Maybe a Serious Health Risk?Aesthetic Plastic Surgery, 2017
- Sequential Survey of Body Piercing and Tattooing Prevalence and Medical Complication Incidence Among College StudentsArchives of Pediatrics & Adolescent Medicine, 2007